Immediate Impact
5 from Science/Nature 60 standout
Citing Papers
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Interstitial Lung Disease
2024 Standout
Works of Julie Olsson being referenced
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
2020
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Julie Olsson | 582 | 576 | 178 | 281 | 13 | 1.1k | |
| May Mo | 486 | 810 | 173 | 369 | 20 | 1.3k | |
| Paul Stryszak | 453 | 587 | 170 | 341 | 20 | 1.3k | |
| Patricia Rohane | 256 | 424 | 42 | 355 | 10 | 955 | |
| Richárd Márkus | 264 | 261 | 318 | 409 | 29 | 1.1k | |
| Angela Morgan | 601 | 921 | 67 | 428 | 10 | 1.1k | |
| Michael C. Nivens | 351 | 395 | 101 | 230 | 24 | 854 | |
| Necdet B. Gunsoy | 634 | 819 | 100 | 207 | 29 | 1.0k | |
| Dana McClintock | 361 | 332 | 28 | 205 | 12 | 850 | |
| Edward Piper | 385 | 665 | 15 | 317 | 8 | 851 | |
| Tuyet‐Hang Pham | 296 | 418 | 42 | 514 | 19 | 1.1k |
All Works
Loading papers...